Biotechnology Ivy Brain Tumor Center and BridgeBio Pharma’s QED Therapeutics Announce Dosing of First Patient in Investigator-Initiated Phase 0/2 Clinical Trial of Infigratinib in Recurrent Glioblastoma July 28, 2020
Biotechnology Amicus Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020 July 28, 2020
Biotechnology Reata Announces Initiation of Investigator-Sponsored Study Evaluating Bardoxolone for Complications Associated with COVID-19 July 28, 2020
Biotechnology Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study July 27, 2020
Biotechnology Acceleron Pharma (XLRN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release July 27, 2020
Search
Biotechnology
